
Financial Reporting
Fiscal year ending 6/30/2024
Statement of Activities
Expenses

Revenue and Support
   Contributions |   $10,476,417 |
   Special Events |   $1,885,502 |
   Other Income |   $217,177 |
  Total Revenue and Support |   $12,579,096 |
  Total Expenses |   $11,806,700 |
  Change in Net Assets before Other Income (Loss) |   $772,396 |
  Investment Income (Loss) |   $4,753,783 |
  Change in Net Assets |   $5,526,179 |
Statement of Financial Position
Assets
   Cash & Cash Equivalents |   $572,093 |
   Contributions and Grants Receivable |   $7,356,846 |
   Investments |   $45,446,931 |
   Other Assets |   $595,803 |
  Total Assets |   $53,971,673 |
Liabilities and Net Assets
  Liabilities | |
   Accounts Payable & Accrued Expenses |   $726,636 |
   Research Grants Payable |   $1,734,688 |
   Other Liabilities |   $929,206 |
  Total Liabilities |   $3,390,530 |
 Net Assets | |
   Undesignated |   $39,354,664 |
   Board designated |   $1,678,649 |
  Net assets with donor restrictions |   $9,547,830 |
  Total Net Assets |   $50,581,143 |
  Total Liabilities and Net Assets |   $53,971,673 |
The Association for Frontotemporal Degeneration is a 501(c)(3) organization.